DR. ANDREW L ONDO, M.D.
Dermatology at Foothills Rd, Las Cruces, NM
License number
New Mexico 97-332
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
3865 Foothills Rd, Las Cruces, NM 88011
Phone
(575) 521-7117
(575) 521-7226 (Fax)
(575) 521-7226 (Fax)
Personal information
See more information about ANDREW L ONDO at radaris.comName
Address
Phone
2930 Hillrise Dr, Las Cruces, NM 88011
4351 Lohman Ave, Las Cruces, NM 88011
2930 Hillrise Dr, Las Cruces, NM 88011
2904 Hillrise Dr, Las Cruces, NM 88011
820 Canterbury Arc, Las Cruces, NM 88005
Organization information
See more information about ANDREW L ONDO at bizstanding.comLas Cruces Dermatology Associate - Andrew L Ondo MD
4351 E Lohman Ave STE 208, Las Cruces, NM 88011
Categories:
Dermatology Physicians & Surgeons, General Surgeons, Physicians & Surgeons
Phone:
(575) 521-7117 (Phone)
Professional information
See more information about ANDREW L ONDO at trustoria.com
Dr. Andrew L Ondo, Las Cruces NM - MD (Doctor of Medicine)
Dr. Andrew L Ondo, Las Cruces NM - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Las Cruces Dermatology Assocs
4351 E Lohman Ave SUITE 208, Las Cruces 88011
(575) 521-7117 (Phone)
4351 E Lohman Ave SUITE 208, Las Cruces 88011
(575) 521-7117 (Phone)
Certifications:
Dermatology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Las Cruces Dermatology Assocs
4351 E Lohman Ave SUITE 208, Las Cruces 88011
Memorial Medical Center
2450 South Telshor Blvd, Las Cruces 88011
Mountain View Regional Medical Center
4311 East Lohman Ave, Las Cruces 88011
4351 E Lohman Ave SUITE 208, Las Cruces 88011
Memorial Medical Center
2450 South Telshor Blvd, Las Cruces 88011
Mountain View Regional Medical Center
4311 East Lohman Ave, Las Cruces 88011
Education:
Medical School
University of Toledo
Graduated: 1993
Case Western Res U/Univ Hosp
SUNY Buffalo/Buffalo Genl Hosp
University of Toledo
Graduated: 1993
Case Western Res U/Univ Hosp
SUNY Buffalo/Buffalo Genl Hosp
Andrew L Ondo, Las Cruces NM
Andrew L Ondo, Las Cruces NM
Specialties:
Dermatologist
Address:
4351 E Lohman Ave, Las Cruces, NM 88011
Education:
Medical College Ohio, Toledo - Doctor of Medicine
Board certifications:
American Board of Dermatology Certification in Dermatology
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
US Patent:
2011002, Feb 3, 2011
Filed:
Oct 11, 2010
Appl. No.:
12/901911
Inventors:
Stuart D. Shanler - Pomona NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
Assignee:
VICEPT THERAPEUTICS, INC. - Malvern PA
International Classification:
A61K 31/4164, A61K 8/00, A61K 31/60, A61K 31/137, A61P 17/10, A61P 17/00, A61Q 17/04
US Classification:
424 59, 514401, 514159, 514653
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
US Patent:
2005016, Jul 28, 2005
Filed:
Jan 22, 2004
Appl. No.:
10/763807
Inventors:
Stuart Shanler - New York NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
International Classification:
A61K031/4164
US Classification:
514401000
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using Α-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using Α-Adrenoceptor Agonists
US Patent:
8420688, Apr 16, 2013
Filed:
May 27, 2010
Appl. No.:
12/788746
Inventors:
Stuart D. Shanler - Pomona NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A01N 43/50, C07D 233/00
US Classification:
514401, 5483471
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
US Patent:
2013019, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/800702
Inventors:
Andrew Ondo - Las Cruces NM, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 31/4174, A61K 45/06, A61K 31/137, A61K 8/49
US Classification:
424401, 514401, 424 59, 514398, 424713, 424490, 514653, 514626, 514654
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
US Patent:
2013019, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/800361
Inventors:
Andrew Ondo - Las Cruces NM, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 31/4174, A61K 45/06, A61Q 19/00, A61K 8/49
US Classification:
424401, 514401, 424 59, 514398, 424713, 424490
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
Method And Therapeutic/Cosmetic Topical Compositions For The Treatment Of Rosacea And Skin Erythema Using A1-Adrenoceptor Agonists
US Patent:
2011003, Feb 10, 2011
Filed:
Oct 11, 2010
Appl. No.:
12/901755
Inventors:
Stuart D. Shanler - Pomona NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
Assignee:
VICEPT THERAPEUTICS, INC. - Malvern PA
International Classification:
A61K 31/60, A61K 31/4164, A61P 17/00, A61P 17/10, A61K 31/137
US Classification:
514159, 514396, 514653
Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.
Compositions And Methods For Treating Purpura
Compositions And Methods For Treating Purpura
US Patent:
8114898, Feb 14, 2012
Filed:
Nov 17, 2008
Appl. No.:
12/272253
Inventors:
Stuart D. Shanler - Pamona NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/133, A61K 31/4172, A61K 31/4164, A61K 31/382, A61K 31/4174, A61K 31/03, A61K 31/155, A61K 31/05, A01N 43/50, A01N 43/54, A01N 33/02
US Classification:
514393, 514385, 514646, 514622, 514601, 5142521, 514595, 5142272
Abstract:
Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an α adrenergic receptor agonist selected from selective αadrenergic receptor agonist, selective αadrenergic receptor agonist, non-selective α/αadrenergic receptor agonist, agents with αadrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
Compositions And Methods For Treating Purpura
Compositions And Methods For Treating Purpura
US Patent:
2012017, Jul 12, 2012
Filed:
Jan 6, 2012
Appl. No.:
13/345472
Inventors:
Stuart D. Shanler - Pamona NY, US
Andrew Ondo - Las Cruces NM, US
Andrew Ondo - Las Cruces NM, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 31/498, A61P 17/00, A61K 31/4164, A61K 31/4174, A61K 31/137
US Classification:
424 59, 514400, 514396, 514653, 514249, 514401
Abstract:
Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an α adrenergic receptor agonist selected from selective αadrenergic receptor agonist, selective αadrenergic receptor agonist, non-selective α/αadrenergic receptor agonist, agents with αadrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.